Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 45 % |
3 Month Return | + 54.2 % |
1 Year Return | + 41.58 % |
Market Stats | |
Previous Close | ₹165.15 |
Open | ₹166.80 |
Volume | 10.43L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹589.42Cr |
P/E Ratio | -54.15 |
PEG Ratio | -23.04 |
Market Cap | ₹589.42 Cr |
P/B Ratio | 3.88 |
EPS | -0.79 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹589.42 Cr | 182.64% | 0.69 | -₹3 Cr | ₹111 Cr | |
BUY | ₹28,124.56 Cr | 20.69% | 0.52 | NA | NA | |
NA | ₹327.69 Cr | 83.66% | 0.52 | NA | NA | |
NA | ₹16.34 Cr | 143.14% | 0.69 | NA | NA | |
NA | ₹478.43 Cr | 339.6% | 0.54 | ₹21 Cr | ₹144 Cr |
Organisation | Lyka Labs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Lyka Labs Ltd
Lyka Labs reports a 38.7% YoY increase in net sales for March 2024, with quarterly net loss at Rs. 1.62 crore, up 46.06% from the previous year. EBITDA stands at Rs. 2.60 crore, down 22.16% YoY. The stock has given -10.47% returns over the last 6 months and 17.26% over the last 12 months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 40.92% to 40.99% in Jun 2024 quarter
Price Rise
In the last 7 days, LYKALABS stock has moved up by 8.4%
Revenue Rich
Revenue is up for the last 2 quarters, 28.08 Cr → 30.67 Cr (in ₹), with an average increase of 8.4% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -2.13 Cr → 1.44 Cr (in ₹), with an average increase of 247.9% per quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.10% of holdings in Jun 2024 quarter
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 79.1% return, outperforming this stock by 37.5%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 132.9% return, outperforming this stock by 5.9%
FII Holding Down
Foreign Institutions have decreased holdings from 0.16% to 0.15% in Jun 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 58.1% | 0.00 | |
Foreign Institutions | 0.15% | ||
Mutual Funds | 0.01% | 0.00 | |
Retail Investors | 40.99% | 0.17 | |
Others | 0.74% |
Lyka Labs Ltd in the last 5 years
Lowest (-164.66x)
September 10, 2018
Today (-54.15x)
September 5, 2024
Industry (58.97x)
September 5, 2024
Highest (23.04x)
September 5, 2022
Lyka Labs Ltd’s net profit jumped 177.84% since last year same period to ₹1.44Cr in the Q1 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 167.61% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Lyka Labs Ltd is currently in a Bullish trading position according to technical analysis indicators.
Lyka Labs Ltd (LYKALABS) share price today is ₹164.61
Lyka Labs Ltd is listed on NSE
Lyka Labs Ltd is listed on BSE
PE Ratio of Lyka Labs Ltd is -54.15
PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share
Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 10.43L.
Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹589.42Cr.
Lyka Labs Ltd(LYKALABS | Price |
---|---|
52 Week High | ₹172.5 |
52 Week Low | ₹97.9 |
Lyka Labs Ltd(LYKALABS) share price is ₹164.61. It is down -4.57% from its 52 Week High price of ₹172.5
Lyka Labs Ltd(LYKALABS) share price is ₹164.61. It is up 68.14% from its 52 Week Low price of ₹97.9
Lyka Labs Ltd(LYKALABS | Returns |
---|---|
1 Day Returns | -0.54% |
1 Month Returns | 45% |
3 Month Returns | 54.2% |
1 Year Returns | 41.58% |